PetVivo Holdings, Inc. (PETV)
OTCMKTS
· Delayed Price · Currency is USD
0.515
-0.035 (-6.36%)
Mar 19, 2025, 10:17 AM EST
PetVivo Holdings Revenue
PetVivo Holdings had revenue of $583.31K in the quarter ending December 31, 2024, a decrease of -2.11%. This brings the company's revenue in the last twelve months to $956.05K, down -8.60% year-over-year. In the fiscal year ending March 31, 2024, PetVivo Holdings had annual revenue of $968.71K with 5.62% growth.
Revenue (ttm)
956.05K
Revenue Growth
-8.60%
P/S Ratio
10.97
Revenue / Employee
47.80K
Employees
20
Market Cap
12.21M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 968.71K | 51.54K | 5.62% |
| Mar 31, 2023 | 917.16K | 801.58K | 693.49% |
| Mar 31, 2022 | 115.59K | 103.01K | 818.95% |
| Mar 31, 2021 | 12.58K | 8.99K | 250.56% |
| Mar 31, 2020 | 3.59K | - | - |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.18B |
| SS Innovations International | 16.04M |
| Veradigm | 1.53B |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| Silence Therapeutics | 43.26M |
| BioStem Technologies | 210.49M |
PetVivo Holdings News
- 16 days ago - Petvivo Holdings, Inc. and Digital Landia Corp. Announce Groundbreaking Strategic Alliance Agreement to Pioneer Agentic AI for Animal Communication - GlobeNewsWire
- 4 weeks ago - Petvivo Holdings, Inc. to Exhibit at the Western Veterinary Conference in Las Vegas, Nevada - GlobeNewsWire
- 4 weeks ago - PetVivo Holdings Inc (PETV) Q3 2025 Earnings Call Highlights: Strategic Expansion Drives ... - GuruFocus
- 4 weeks ago - Q3 2025 PetVivo Holdings Inc Earnings Call Transcript - GuruFocus
- 4 weeks ago - PetVivo Reports Fiscal Q3 2025 Results - GlobeNewsWire
- 4 weeks ago - PetVivo Signs Exclusive Sales and Marketing Agreement with VetStem for PrecisePRP® Canine and Equine Products - GlobeNewsWire
- 5 weeks ago - PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024 - GlobeNewsWire
- 7 weeks ago - PetVivo Engages Former Dechra North American President, Mike Eldred as Commercial and Operations Advisor - GlobeNewsWire